The 16 references in paper M. Batyushin M., A. Galushkin A., D. Pasechnik G., A. Litvinov S., M. Gasanov Z., N. Sadovnichaya A., D. Tsvetkov S., М. Батюшин М., А. Галушкин А., Д. Пасечник Г., А. Литвинов С., М. Гасанов З., Н. Садовничая А., Д. Цветков С. (2012) “КЛИНИЧЕСКИЙ СЛУЧАЙ С1q-НЕФРОПАТИИ // CLINICAL CASE OF C1Q – NEPHROPATHY” / spz:neicon:nefr:y:2012:i:1:p:117-121

1
Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985; 6: 103–110
(check this in PDF content)
2
Nachman PH, Jennette JC, Falk RJ. Primary Glomerular Disease. In 8th ed. Brenner BM: The Kidney. Brenner and Rector’s, 2007; 1006-1007
(check this in PDF content)
3
Nishida M, Kawakatsu H, Komatsu H, et al. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis 2000; 35:E22
(check this in PDF content)
4
Bohnsack JF, Tenner AJ, Laurie GW et al. The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane. Proc Nat Acad Sci 1985; 82: 3824–3828
(check this in PDF content)
5
Dobbelsteen ME, van der Woude FJ, Schroeijers WE et al. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. J Am Soc Nephrol 1996; 7:573–581
(check this in PDF content)
6
Fukuma Y, Hisano S, Segawa Y et al. Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis 2006; 47: 412–418
(check this in PDF content)
7
Hisano S, Fukuma Y, Segawa Y et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 2008; 3:1637–1643
(check this in PDF content)
8
Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 1991; 18: 459–465
(check this in PDF content)
9
Markowitz GS, Schwimmer JA, Stokes MB et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 2003; 64:1232–1240
(check this in PDF content)
10
Kersnik LT, Kenda RB, Avgustin CM et al. C1Q nephropathy in children. Pediatr Nephrol 2005; 20: 1756–1761
(check this in PDF content)
11
Lau KK, Gaber LW, Delos Santos N Met al.C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 2005; 20: 744–749
(check this in PDF content)
12
Davenport A, Maciver AG, Mackenzie JC C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant 1992; 7: 391–396
(check this in PDF content)
13
Sharman A, Furness P, Feehally J Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 2004; 19: 1420–1426
(check this in PDF content)
14
Vizjak A, Ferluga D, Rozic M et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008; 19: 2237–2244
(check this in PDF content)
15
Roberti I, Baqi N, Vyas S et al. Asingle-center study of C1q nephropathy in children. Pediatr Nephrol 2009; 24: 77–82
(check this in PDF content)
16
Wong CS, Fink CA, Baechle J et al. C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol 2009; 24: 761–767 Поступила в редакцию 05.04.2012 г. Принята в печать 28.06.2012 г.
(check this in PDF content)